Tuesday, January 12, 2021

Update on Gilead Science - good news


I have a large investment of $104,000 USD in Gilead Science (GILD). It is now showing a loss of 22% or $22,600.

I bought this stock when the US and several other governments approved the remdesivir drug for treatment of covid-19. The subsequent reports on this drug was not great. Many investors sold the stock. I kept the stock because it has a good dividend yield of 4.31%. However, the price earning ratio is rather high. I just saw a good news for this stock. The news has not been reflected in the stock price yet. I will monitor the price closely over the next few days. https://fisca.sg/ArticleDisplay.aspx?ID=818

No comments:

Post a Comment